INTEGRATED PROTEINS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.83 INR | +0.13% |
|
-0.19% | -8.23% |
Valuation
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 7.828 | 7.849 | 7.849 | 10.38 | 48.05 | 38.35 |
| Enterprise Value (EV) 1 | 3.755 | 4.499 | 5.758 | 8.971 | 48.5 | 39.99 |
| P/E ratio | 55.9 x | 31.7 x | 141 x | 49 x | 136 x | 133 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | - | - | - | - | - | 22,962,331 x |
| EV / Revenue | - | - | - | - | - | 23,946,762 x |
| EV / EBITDA | -4.44 x | -3.22 x | -4.92 x | -8.79 x | -62.7 x | -47 x |
| EV / FCF | -1.89 x | 5.14 x | -6.27 x | -25.2 x | -138 x | -63.2 x |
| FCF Yield | -53% | 19.5% | -16% | -3.97% | -0.72% | -1.58% |
| Price to Book | 0.27 x | 0.32 x | 0.32 x | 0.42 x | 1.93 x | 1.52 x |
| Nbr of stocks (in thousands) | 3,675 | 3,204 | 3,204 | 3,204 | 3,204 | 3,204 |
| Reference price 2 | 2.130 | 2.450 | 2.450 | 3.240 | 15.00 | 11.97 |
| Announcement Date | 29/08/18 | 04/09/19 | 08/09/20 | 01/09/21 | 17/08/22 | 28/08/23 |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales | - | - | - | - | - | 1.67 |
| EBITDA 1 | -0.8458 | -1.397 | -1.17 | -1.021 | -0.774 | -0.85 |
| EBIT 1 | -1.134 | -1.685 | -1.459 | -1.309 | -1.062 | -1.138 |
| Operating Margin | - | - | - | - | - | -68.14% |
| Earnings before Tax (EBT) 1 | 0.6418 | 0.0315 | 0.1845 | 0.2865 | 0.494 | 0.418 |
| Net income 1 | 0.1222 | 0.2475 | 0.0556 | 0.212 | 0.365 | 0.309 |
| Net margin | - | - | - | - | - | 18.5% |
| EPS 2 | 0.0381 | 0.0773 | 0.0174 | 0.0662 | 0.1100 | 0.0900 |
| Free Cash Flow 1 | -1.99 | 0.8761 | -0.9184 | -0.3559 | -0.3504 | -0.6332 |
| FCF margin | - | - | - | - | - | -37.92% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | 353.98% | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 29/08/18 | 04/09/19 | 08/09/20 | 01/09/21 | 17/08/22 | 28/08/23 |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | 0.44 | 1.64 |
| Net Cash position 1 | 4.07 | 3.35 | 2.09 | 1.41 | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | -0.5724 x | -1.934 x |
| Free Cash Flow 1 | -1.99 | 0.88 | -0.92 | -0.36 | -0.35 | -0.63 |
| ROE (net income / shareholders' equity) | 0.48% | 1% | 0.23% | 0.87% | 1.48% | 1.23% |
| ROA (Net income/ Total Assets) | -2.71% | -4.06% | -3.57% | -3.18% | -2.51% | -2.59% |
| Assets 1 | -4.507 | -6.098 | -1.556 | -6.672 | -14.55 | -11.95 |
| Book Value Per Share 2 | 7.930 | 7.570 | 7.590 | 7.660 | 7.770 | 7.870 |
| Cash Flow per Share 2 | 0.0900 | 0.1200 | 0.0900 | 0.2200 | 0.1100 | 0.0800 |
| Capex | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - |
| Announcement Date | 29/08/18 | 04/09/19 | 08/09/20 | 01/09/21 | 17/08/22 | 28/08/23 |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- INTEGFD6 Stock
- Financials Integrated Proteins Limited
